| URN | urn:agi-cas:53-59-8 |
|---|---|
| Total Entities | 9 |
| Connectivity | 783 |
| Name | NADP+ |
| ChildConcepts | NADH |
|---|---|
| NAD+ | |
| NADPH | |
| carba-NAD | |
| Deaminocozymase | |
| 3-Apadn | |
| NFDH | |
| 3'-phospho-ADP | |
| 2'-Deoxy NAD |
| Pathway | Neurotoxin-Induced Parkinson's Disease |
|---|---|
| Role of Polyol Pathway in Diabetic Microangiopathy | |
| Peripheral Tissue Microangiopathy in Insulin Resistance | |
| Pancreatic Beta-cell Death in Diabetes Mellitus Type 2 | |
| Defective Clearance of Apoptotic Keratinocytes in Systemic Lupus Erythematosus | |
| Hemoglobin Reduction and Leukocyte Adhesion Initiate Vasospasm | |
| CFTR Up-regulates the Oxidative Stress in Airway Epithelium in Cystic Fibrosis | |
| Diabetes-Induced Cataract | |
| Tricarboxylic acid cycle | |
| Pentose-phosphate shunt | |
| Mannose metabolism | |
| Serine and Glycine metabolism | |
| Tryptophan metabolism | |
| Phenylalanine and Tyrosine metabolism | |
| Ser/Gly/Thr/Cys metabolism | |
| Lysine metabolsm | |
| Urea cycle and arginine metabolism | |
| Glu/Gln/Pro metabolsm | |
| Methionine metabolism | |
| Purine metabolism | |
| Pyrimidine metabolism | |
| Nicotinate and nicotinamide metabolism | |
| Pterine biosynthesis | |
| Folate biosynthesis | |
| Heme oxidation | |
| Bile acids metabolism | |
| Biosynthesis of cholesterol | |
| Metabolism of glucocorticoids and mineralcorticoids | |
| Metabolism of estrogens and androgens | |
| Arachidonic acid metabolism | |
| Metabolism of triacylglycerols | |
| Sphingolipid metabolism | |
| ROS metabolism | |
| Fatty acid oxidation | |
| Metabolism of glycerophospholipids and ether lipids | |
| Fatty acid biosynthesis | |
| Bile acid metabolism (alternative pathway) | |
| Galactose metabolism | |
| Ascorbate biosyntesis | |
| Pyruvate metabolism | |
| L-sugars oxidation | |
| Vitamin A (retinol) metabolism and visual cycle | |
| Glutathione metabolism | |
| Malonate, propanoate and beta-alanine metabolism | |
| Riboflavin metabolism | |
| Caffeine metabolism | |
| Selencompound biosynthesis | |
| Ethanol metabolism | |
| Omega-3-fatty acid metabolism | |
| Glyoxylate and glycerate metabolism | |
| D-amino acid metabolism | |
| Mevalonate pathway | |
| Omega-6-fatty acid metabolism | |
| Ubiquinoine biosynthesis | |
| Ubiquinoine biosynthesis in humans | |
| Ubiquinoine biosynthesis in rats | |
| Cholesterol catabolism | |
| Capecitabine and Fluorafur metabolism | |
| ROS in Neutrophil-Mediated Cell Damage | |
| altered retinoid cycle metabolic pathway | |
| steroid hormone biosynthetic pathway | |
| testosterone biosynthetic pathway | |
| nicotinamide adenine dinucleotide metabolic pathway |
| Group | Biofluids assayable substances |
|---|
| Source | ChemIDplus |
|---|
| Alias | TPN+ |
|---|---|
| NADP | |
| NADP(+) | |
| NADP, triphosphopyridine | |
| NADP+ | |
| NAD-PH | |
| NADP-ox | |
| NADP-oxidized | |
| nicotinamide adenine dinucleotide-P | |
| nicotinamide-adenine-dinucleotide-phosphate-anion | |
| o-NADP | |
| 3-carbamoyl-1-beta-d-ribofuranosyl-pyridinium hydroxide 5',5'-ester w/adenosine 2'-(dihydrogen phosphate) | |
| TPN (nucleotide) | |
| TPN-ox | |
| Triphosphopyridine nucleotide | |
| 53-59-8 | |
| triphosphopyridine NADP | |
| Coenzyme II | |
| Nadide phosphate | |
| pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, hydroxide, 5',5'-ester w/adenosine 2'-(dihydrogen phosphate) | |
| [4-3H]NADP | |
| EINECS 200-178-1 | |
| NAD(P)(+) | |
| [(3)H]NADP | |
| [14C]NADP | |
| Adenine-nicotinamide dinucleotide phosphate | |
| Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'->'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt | |
| beta-NADP | |
| beta-nicotinamide adenine dinucleotide phosphate | |
| beta-Nicotinamide adenine dinucleotide phosphate hydrate | |
| beta-TPN | |
| Cozymase II | |
| b-nicotinamide adenine dinucleotide phosphate free acid | |
| BRN 3885115 | |
| b-TPN | |
| Codehydrase II | |
| Codehydrogenase II | |
| NAD phosphate | |
| b-Nicotinamide adenine dinucleotide phosphate | |
| adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'.fwdarw.'-ester with 3-(aminocarbonyl)-1- beta-d-ribofuranosylpyridinium hydroxide, inner salt | |
| Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'fwdarw5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt | |
| 1-[5-[[[[5-[(6-amino-9H-purin-9-yl)]-3-hydroxy-4-(hydroxy-oxido-phosphinoyl)oxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphinoyl]oxy-oxido-phosphinoyl]oxymethyl]-3,4-dihydroxy-tetrahydrofuran-2-yl]-1H-pyridine-5-carboxamide | |
| [(3)H]NADP() | |
| [14C] NADP | |
| nicotinamide adenine denucleotide phosphate | |
| Nicotinamide adenine dinucleotide phosphate | |
| nicotinamide adeninine dinucleotide phosphate | |
| nicotinamideadenine-dinucleotide |
| KEGG ID | C00006 |
|---|
| MedScan ID | 1082233 |
|---|
| HMDB ID | HMDB00217 |
|---|
| CAS ID | 10213-33-9 |
|---|---|
| 162195-92-8 | |
| 25158-33-2 | |
| 27678-67-7 | |
| 53-59-8 |
| PubChem SID | 134971348 |
|---|---|
| 148688 |
| PubChem CID | 5885 |
|---|
| IUPAC Name | [[(2R,3R,4R,5R)-5-adenin-9-yl-3-hydroxy-4-phosphonooxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate |
|---|
| InChIKey | XJLXINKUBYWONI-NNYOXOHSSA-N |
|---|
| Rotatable Bond Count | 13 |
|---|
| Molecular Weight | 743.405006 |
|---|---|
| 743.405003 |
| Molecular Formula | C21H28N7O17P3 |
|---|
| XLogP | -7.100000 |
|---|---|
| -7.100000 |
| ChEBI ID | 18009 |
|---|---|
| 44409 |
| Reaxys ID | 3885115 |
|---|---|
| 4109776 | |
| 4121922 | |
| 5712848 | |
| 6264600 | |
| 6765327 |
| LinkUrl | http://rgd.mcw.edu/rgdweb/ontology/annot.html?acc_id=CHEBI:18009 |
|---|